WHO estimated that nearly 1 million people become infected every day with any of four
curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and …

Background Bacterial vaginosis (BV) is the most common vaginal infection among women of
reproductive age and is associated with important adverse health outcomes. Estimates of …

We report the results of a first exploratory study testing the use of vaginal microbiome
transplantation (VMT) from healthy donors as a therapeutic alternative for patients suffering …

Bacterial vaginosis (BV) is the most common vaginal dysbiosis to affect women globally, yet
an unacceptably high proportion of women experience BV recurrence within 6 months of …

Practitioners and patients alike widely recognize the limitations of current therapeutic
approaches to the treatment of bacterial vaginosis (BV). Options remain extremely limited …

The vaginal microbiota has importance in preserving vaginal health and defending the host
against disease. The advent of new molecular techniques and computer science has …

Objective Bacterial vaginosis (BV) is a common cause of genital discomfort in women in
reproductive ages, which causes many complications. Bacterial vaginosis is usually treated …

Bacterial Vaginosis (BV) is a complex polymicrobial infection of vagina that shifts the
paradigms of vaginal flora from lactobacilli to opportunistic pathogens. BV is catagorized by …

The intricate interactions between the host cells, bacteria, and immune components that
reside in the female reproductive tract (FRT) are essential in maintaining reproductive tract …

Bacterial vaginosis (BV) is a common cause of vaginitis worldwide and is associated with
serious reproductive health outcomes, including increased risk of preterm birth, sexually …